Novavax Inc said on Thursday its vaccine to prevent RSV infection, a leading cause of a respiratory disease in infants, failed to meet the main goal of a late stage study.
from Reuters: Health News https://ift.tt/2EjGBUU
via IFTTT
Thursday, February 28, 2019
Home »
Reuters: Health News
» Novavax respiratory infection vaccine fails in late-stage trial
0 comments:
Post a Comment